Combination with isatuximab can be used in newly diagnosed multiple...

Combination with isatuximab can be used in newly diagnosed multiple…

0 Comments

medicine

Friday, November 22, 2024

Lille The combination of bortezomib, lenalidomide and dexamethasone (VRd) is a preferred first-line therapy for patients with newly diagnosed multiple myeloma. Researchers led by Thierry Facon, University of Lille, demonstrated in the current evaluation of the…

#Combination #isatuximab #newly #diagnosed #multiple..

Leave a Reply

Related Posts